Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.

Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, Campbell J, Mechinaud F, Campbell M, Super L, Chantranuwat C, Yuen ST, Chan JKC, Chow CW.

Mod Pathol. 2019 May;32(5):598-608. doi: 10.1038/s41379-018-0168-6. Epub 2018 Dec 20.

PMID:
30573850
2.

The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes.

Neeland MR, Shi W, Collignon C, Taubenheim N, Meeusen EN, Didierlaurent AM, de Veer MJ.

J Immunol. 2016 Oct 1;197(7):2704-14. doi: 10.4049/jimmunol.1600817. Epub 2016 Aug 22.

3.

Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.

Shi W, Liao Y, Willis SN, Taubenheim N, Inouye M, Tarlinton DM, Smyth GK, Hodgkin PD, Nutt SL, Corcoran LM.

Nat Immunol. 2015 Jun;16(6):663-73. doi: 10.1038/ni.3154. Epub 2015 Apr 20.

PMID:
25894659
4.

Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.

Corcoran L, Emslie D, Kratina T, Shi W, Hirsch S, Taubenheim N, Chevrier S.

Front Immunol. 2014 Mar 20;5:108. doi: 10.3389/fimmu.2014.00108. eCollection 2014.

5.

High rate of antibody secretion is not integral to plasma cell differentiation as revealed by XBP-1 deficiency.

Taubenheim N, Tarlinton DM, Crawford S, Corcoran LM, Hodgkin PD, Nutt SL.

J Immunol. 2012 Oct 1;189(7):3328-38. Epub 2012 Aug 27.

6.

The genetic network controlling plasma cell differentiation.

Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD.

Semin Immunol. 2011 Oct;23(5):341-9. doi: 10.1016/j.smim.2011.08.010. Epub 2011 Sep 15. Review.

PMID:
21924923
7.

The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.

Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, Nakada S, Ylanko J, Olivarius S, Mendez M, Oldreive C, Wildenhain J, Tagliaferro A, Pelletier L, Taubenheim N, Durandy A, Byrd PJ, Stankovic T, Taylor AM, Durocher D.

Cell. 2009 Feb 6;136(3):420-34. doi: 10.1016/j.cell.2008.12.042.

8.

Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.

Durandy A, Taubenheim N, Peron S, Fischer A.

Adv Immunol. 2007;94:275-306. Review.

PMID:
17560278
9.

A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.

Péron S, Pan-Hammarström Q, Imai K, Du L, Taubenheim N, Sanal O, Marodi L, Bergelin-Besançon A, Benkerrou M, de Villartay JP, Fischer A, Revy P, Durandy A.

J Exp Med. 2007 May 14;204(5):1207-16. Epub 2007 May 7.

10.

Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.

Durandy A, Peron S, Taubenheim N, Fischer A.

Hum Mutat. 2006 Dec;27(12):1185-91. Review.

PMID:
16964591
11.
12.

Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients.

Taubenheim N, von Hornung M, Durandy A, Warnatz K, Corcoran L, Peter HH, Eibel H.

J Immunol. 2005 Oct 15;175(8):5498-503. Erratum in: J Immunol. 2006 Feb 15;176(4):2670.

Supplemental Content

Loading ...
Support Center